Chiari I malformation management in patients with heritable connective tissue disorders.

BACKGROUND

Chiari malformation type I (CMI) is relatively common neurosurgical condition typically treated with posterior fossa decompression. However, the management of CMI in patients with heritable connective tissue disorders (CTDs), such as Ehlers-Danlos Syndrome, Marfan Syndrome, or Osteogenesis Imperfecta, involves a unique set of perioperative challenges.

OBJECTIVE

This study aims to define the demographic information, comorbidities, and perioperative course of patients with concomitant CMI and CTD.

METHODS

Patients with CMI admitted for surgical decompression from 2008 to 2015 were captured using the National Inpatient Sample (NIS). Information was collected based on ICD-9 codes. Descriptive and regression analyses were performed in SPSS (version 26).

RESULTS

38,169 CMI patients, 353 of whom had CTD (0.92%), were identified. CMI patients with CTD were more likely to be female ( < 0.001) and present during teenage ( = 0.033) or young adult years ( < 0.001). They had more chronic issues ( < 0.001): systemic comorbidities include postural orthostatic tachycardia syndrome, cardiac dysrhythmias, and gastroparesis (all  < 0.001). CNS comorbidities include migraine, tethered spinal cord, and epilepsy (all  < 0.001). They have increased joint instability (both  < 0.001), as well as craniocervical instability (CCI). More posterior cervical fusion surgeries and application of cervical halo devices were seen during the same inpatient stay (both  < 0.001).

CONCLUSIONS

Patients with concurrent CTD and CMI were more likely to present with complex Chiari and associated CCI. They were also younger, more often female, and had more systemic, CNS, and joint abnormalities. As such, preoperative recognition of an underlying CTD is imperative to achieve optimal outcomes in this patient population.